NATIKA WASHINGTON: Open Payments
NPI 1346883030 · BROWNSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 31 payments from 10 companies in 2025. Trend: 2023 $118 · 2024 $477 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $241 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Orexo US, Inc. | 3 | $47 |
| Gilead Sciences, Inc. | 2 | $38 |
| Braeburn Inc. | 2 | $35 |
| Indivior Inc. | 2 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Tris Pharma Inc | 1 | $17 |
| Corium, LLC | 1 | $16 |
Products named: MAVYRET, Auvelity, REXULTI, Zubsolv, BRIXADI, SUBLOCADE, ABILIFY MAINTENA, JOURNAVX.
Industry payments across IN — which companies pay providers there.
